ACCUREP Trademark

Trademark Overview

On Friday, March 23, 2018, a trademark application was filed for ACCUREP with the United States Patent and Trademark Office. The USPTO has given the ACCUREP trademark a serial number of 87847472. The federal status of this trademark filing is ABANDONED PETITION TO REVIVE - DENIED as of Friday, June 21, 2019. This trademark is owned by Valeant Pharmaceuticals Ireland Limited. The ACCUREP trademark is filed in the Medical Instrument Products category with the following description:

Software for medical cosmetic equipment, namely, software featuring an algorithm for measuring and tuning the amount of radio frequency energy delivered to a patient's treatment area sold as an integral component of medical devices for cosmetic skin procedures
accurep

General Information

Serial Number87847472
Word MarkACCUREP
Filing DateFriday, March 23, 2018
Status614 - ABANDONED PETITION TO REVIVE - DENIED
Status DateFriday, June 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Goods and ServicesSoftware for medical cosmetic equipment, namely, software featuring an algorithm for measuring and tuning the amount of radio frequency energy delivered to a patient's treatment area sold as an integral component of medical devices for cosmetic skin procedures

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 30, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBAUSCH HEALTH IRELAND LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressDUBLIN 24
IE
Party NameValeant Pharmaceuticals Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressDublin 24
IE
Party NameValeant Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressDublin 24
IE

Trademark Events

Event DateEvent Description
Wednesday, April 11, 2018ASSIGNED TO EXAMINER
Thursday, April 12, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 27, 2018NEW APPLICATION ENTERED
Friday, March 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 12, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 13, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, April 13, 2018EXAMINER'S AMENDMENT ENTERED
Friday, April 13, 2018EXAMINERS AMENDMENT E-MAILED
Friday, April 13, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2018ASSIGNED TO LIE
Wednesday, March 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 11, 2019PETITION TO REVIVE-RECEIVED
Monday, February 11, 2019PETITION TO REVIVE-GRANTED
Monday, February 11, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, February 11, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, February 11, 2019NOTICE OF REVIVAL - E-MAILED
Thursday, April 25, 2019ASSIGNED TO PETITION STAFF
Wednesday, July 10, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 16, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 1, 2019INCOMPLETE PETITION NOTICE MAILED
Friday, June 21, 2019PETITION TO REVIVE-DENIED

Related Keywords

accurep software cosmetic medical area treatment patient sold component procedures skin